5
H index
4
i10 index
121
Citations
Simon Walker : Citation Profile
| RESEARCH PRODUCTION: 17 Articles 10 Papers RESEARCH ACTIVITY:
MORE DETAILS IN: ABOUT THIS REPORT:
|
11 years (2010 - 2021). Relations with other researchers
Works with:
Authors registered in RePEc who have co-authored more than one work in the last five years with Simon Walker. | Is cited by:
| Cites to:
|
Main data
Where Simon Walker has published?
| Journals with more than one article published | # docs |
|---|---|
| PharmacoEconomics | 5 |
| Medical Decision Making | 4 |
| PharmacoEconomics - Open | 2 |
| Health Economics | 2 |
| Working Papers Series with more than one paper published | # docs |
|---|---|
| Working Papers / Centre for Health Economics, University of York | 8 |
Recent works citing Simon Walker (2024 and 2023)
| Year | Title of citing document |
|---|---|
| 2023 | Pricing Treatments Cost-Effectively when They Have Multiple Indications: Not Just a Simple Threshold Analysis. (2023). Cipriano, Lauren E ; Goldhaber-Fiebert, Jeremy D. In: Medical Decision Making. RePEc:sae:medema:v:43:y:2023:i:7-8:p:914-929. Full description at Econpapers || Download paper |
| 2023 | The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework. (2023). Vallejo-Torres, Laura. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:21:y:2023:i:3:d:10.1007_s40258-023-00801-z. Full description at Econpapers || Download paper |
| 2023 | How Much Should be Invested in Lung Care Across the WHO European Region? Applying a Monetary Value to Disability-Adjusted Life-Years Within the International Respiratory Coalition’s Lung Facts. (2023). Joos, Guy ; Welte, Tobias ; Angus, Colin ; Franklin, Matthew. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:21:y:2023:i:4:d:10.1007_s40258-023-00802-y. Full description at Econpapers || Download paper |
| 2023 | Estimating loss in capability wellbeing in the first year of the COVID-19 pandemic: a cross-sectional study of the general adult population in the UK, Australia and the Netherlands. (2023). Husbands, Samantha ; Hiligsmann, Mickael ; Morton, Rachael L ; Mitchell, Paul Mark ; Coast, Joanna. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:4:d:10.1007_s10198-022-01498-y. Full description at Econpapers || Download paper |
| 2023 | How is the Societal Perspective Defined in Health Technology Assessment? Guidelines from Around the Globe. (2023). Lorgelly, Paula ; Yang, Xiaozhe ; Avar, Tuba Saygin. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:2:d:10.1007_s40273-022-01221-y. Full description at Econpapers || Download paper |
| 2023 | Capturing the Impact of Constraints on the Cost-Effectiveness of Cell and Gene Therapies: A Systematic Review. (2023). Payne, Katherine ; Thistlethwaite, Fiona ; Wright, Stuart J ; Gavan, Sean P. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:6:d:10.1007_s40273-022-01234-7. Full description at Econpapers || Download paper |
| 2023 | The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice. (2023). Brouwer, Werner ; Versteegh, Matthijs ; Baal, Pieter ; Wouterse, Bram. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:6:d:10.1007_s40273-023-01265-8. Full description at Econpapers || Download paper |
| 2023 | Partially different? The importance of general equilibrium in health economic evaluations: An application to nocturia. (2023). Yerushalmi, Erez ; Burtea, Teodor ; Andersson, Fredrik L ; Hafner, Marco. In: Health Economics. RePEc:wly:hlthec:v:32:y:2023:i:3:p:654-674. Full description at Econpapers || Download paper |
Works by Simon Walker:
| Year | Title | Type | Cited |
|---|---|---|---|
| 2019 | Incorporating concerns for equity into health resource allocation. A guide for practitioners In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
| 2019 | Economic analysis for health benefits package design In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
| 2019 | Applying the three core concepts of economic evaluation in health to education in the UK In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
| 2020 | Does Health Technology Assessment guidance give adequate consideration to decisions about less costly and less effective alternatives? In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
| 2021 | Comparing smoking cessation to screening and brief intervention for alcohol in distributional cost effectiveness analysis to explore the sensitivity of results to socioeconomic inequalities characteri In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
| 2010 | Appropriate Perspectives for Health Care Decisions In: Working Papers. [Full Text][Citation analysis] | paper | 45 |
| 2012 | Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions In: Working Papers. [Full Text][Citation analysis] | paper | 24 |
| 2014 | Using cost-effectiveness thresholds to determine value for money in low- and middle-income country healthcare systems: Are current international norms fit for purpose? In: Working Papers. [Full Text][Citation analysis] | paper | 10 |
| 2019 | Striving for a societal perspective: a framework for economic evaluations when costs and effects fall on multiple sectors and decision-makers In: LSE Research Online Documents on Economics. [Full Text][Citation analysis] | paper | 18 |
| 2019 | Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers.(2019) In: Applied Health Economics and Health Policy. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 18 | article | |
| 2016 | Using electronic health records to predict costs and outcomes in stable coronary artery disease In: LSE Research Online Documents on Economics. [Full Text][Citation analysis] | paper | 3 |
| 2015 | Sustainable HIV treatment in Africa through viral-load-informed differentiated care In: Nature. [Full Text][Citation analysis] | article | 0 |
| 2018 | Reflecting the real value of health care resources in modelling and cost-effectiveness studies—The example of viral load informed differentiated care In: PLOS ONE. [Full Text][Citation analysis] | article | 0 |
| 2017 | How to Invest in Getting Cost-effective Technologies into Practice? A Framework for Value of Implementation Analysis Applied to Novel Oral Anticoagulants In: Medical Decision Making. [Full Text][Citation analysis] | article | 4 |
| 2018 | Establishing the Value of Diagnostic and Prognostic Tests in Health Technology Assessment In: Medical Decision Making. [Full Text][Citation analysis] | article | 2 |
| 2020 | Impact of Socioeconomic Differences on Distributional Cost-effectiveness Analysis In: Medical Decision Making. [Full Text][Citation analysis] | article | 0 |
| 2021 | Uncertainty Analysis in Intervention Impact on Health Inequality for Resource Allocation Decisions In: Medical Decision Making. [Full Text][Citation analysis] | article | 0 |
| 2017 | Cost-effectiveness analysis of new generation coronary CT scanners for difficult-to-image patients In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2012 | Omalizumab for the Treatment of Severe Persistent Allergic Asthma in Children Aged 6–11 Years In: PharmacoEconomics. [Full Text][Citation analysis] | article | 3 |
| 2016 | Using Linked Electronic Health Records to Estimate Healthcare Costs: Key Challenges and Opportunities In: PharmacoEconomics. [Full Text][Citation analysis] | article | 5 |
| 2016 | Using Linked Electronic Health Records to Estimate Healthcare Costs: Key Challenges and Opportunities.(2016) In: PharmacoEconomics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 5 | article | |
| 2019 | An Educational Review About Using Cost Data for the Purpose of Cost-Effectiveness Analysis In: PharmacoEconomics. [Full Text][Citation analysis] | article | 4 |
| 2021 | Jointly Modelling Economics and Epidemiology to Support Public Policy Decisions for the COVID-19 Response: A Review of UK Studies In: PharmacoEconomics. [Full Text][Citation analysis] | article | 1 |
| 2018 | Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease In: PharmacoEconomics - Open. [Full Text][Citation analysis] | article | 1 |
| 2019 | Correction to: Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease In: PharmacoEconomics - Open. [Full Text][Citation analysis] | article | 0 |
| 2020 | Distributional cost effectiveness analysis of West Yorkshire low emission zone policies In: Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2021 | Cost?effectiveness analysis of public health interventions with impacts on health and criminal justice: An applied cross?sectoral analysis of an alcohol misuse intervention In: Health Economics. [Full Text][Citation analysis] | article | 1 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated December, 10 2023. Contact: CitEc Team